Cannabis and Cannabinoid Research

The endocannabinoid system is a signaling network built around two primary receptor types, CB1 and CB2, that are distributed across the brain, immune tissue, and peripheral organs, where they help regulate processes ranging from synaptic transmission to metabolic balance. Pharmacologists studying cannabis and its active compounds are working to understand how activating or blocking these receptors produces effects on mood, cognition, pain, and inflammation — and how those effects might be harnessed in conditions such as epilepsy, multiple sclerosis, anxiety disorders, and obesity. Medical marijuana has moved faster into clinical use than the underlying science has moved into consensus, leaving open questions about long-term psychiatric risk, optimal dosing, and which specific cannabinoids or receptor pathways drive therapeutic versus adverse outcomes. A central challenge now is disentangling the dozens of biologically active compounds in the cannabis plant to develop targeted treatments that capture clinical benefit without the cognitive or psychoactive side effects associated with broad cannabis use.

Works

95,901

Total citations

2,143,366

Keywords

Endocannabinoid SystemCannabinoid ReceptorsCannabis UseNeurological DisordersPsychiatric EffectsMetabolic Disorders